Is a complete ASX/BP8 research report available?

No complete published report is available for asx/BP8 (ASX/BP8) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ASX/BP8 (ASX/BP8)

Australian Securities Exchange: ASX/BP8 · AUD

A$0.00

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ASX/BP8 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	4.7M
Revenue (ttm)	1.7M
Net income (ttm)	-2.1M
EPS (ttm)	-A$0.00
Shares out	2.4B
Volume	250,000
Beta	0.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7M
Net income (ttm): -2.1M
EPS (ttm): -A$0.00
Market cap: 4.7M

All ASX/BP8 indicators

Market & fundamental data

Available fields

154

Groups with data

Currency

AUD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	31
Enterprise value	AUD 4.7M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	AU000000SCU9
Last refreshed	2026-07-29
Market cap	AUD 4.7M
Price	AUD 0
Price currency	AUD
Rev Per Employee	55,740.61x
Sector	Healthcare
Sector PE	69.28
Sector PE Fwd	27.04
Sic	2836
Symbol	asx/BP8
Website	https://bphglobal.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-45.28%
EV/Sales	2.7x
FCF yield	-36.46%
P/B ratio	-5.91x
P/S ratio	2.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-116.24%
EBITDA Margin	-115.92%
Gross margin	-2.07%
Gross Profit	AUD -35,788
Net Income	AUD -2.1M
Net Income Growth Years	2%
Pretax Margin	-124.84%
Profit Margin	-123.35%
Profit Per Employee	AUD -68,754
ROA	-172.5
Roa5y	-84.59
ROCE	252.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr3y	-45.7%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	1,471.37x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	370.66x
Revenue Growth5 Y	-14.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 2.37
Assets	AUD 1.2M
Cash	AUD 598,604
Current Assets	AUD 1.1M
Current Liabilities	AUD 1.9M
Debt	AUD 577,475
Debt FCF	AUD -0.34
Equity	AUD -795,969
Interest Coverage	-45.39
Liabilities	AUD 1.9M
Long Term Assets	AUD 28,364
Long Term Liabilities	AUD 0
Net Cash	AUD 21,129
Net Cash By Market Cap	AUD 0.45
Tangible Book Value	AUD -781,811
Tangible Book Value Per Share	AUD -0
WACC	7.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.58
Inventory Turnover	26.34
Net Working Capital	AUD -845,462
Quick ratio	0.52
Working Capital	AUD -824,333
Working Capital Turnover	AUD -1.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-146.69%
Dividend per share	AUD 0
Last Dividend	AUD 4.4

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	0
3Y total return	-84%
50-day SMA	0
50-day SMA vs 200-day SMA	50under200
All Time High	0.03
All Time High Change	-93.33%
All Time High Date	2023-03-30
All Time Low	0
All Time Low Change	100%
All Time Low Date	2025-06-04
ATR	0
Beta	0.53
Beta1y	0.9
Beta2y	1
High	0
High52	0
High52 Date	2026-02-17
High52ch	-33.33%
Low	0
Low52	0
Low52 Date	2026-07-08
Low52ch	100%
Ma50ch	11.11%
Price vs 200-day SMA	5.26%
RSI	53.98
RSI Monthly	30.69
RSI Weekly	50.99
Sharpe ratio	1.46x
Sortino ratio	2.95
Total Return	-146.69%
Tr1m	100%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -2M
Operating margin	-116.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,386,630,067%
Net Borrowing	548,246
Shares Insiders	37.87%
Shares Institutions	0.77%
Shares Out	2,353,484,651
Shares Qo Q	76.27%
Shares Yo Y	146.69%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,232,422.1x
Bv Per Share	-0
CAPEX	AUD -4,294
Ch1m	100
Ch3y	-84
Change	0%
Change From Open	0
Close	0
Days Gap	0
Depreciation Amortization	5,517
Dollar Volume	500
Earnings Date	2026-08-28
EBIT	AUD -2M
EBITDA	AUD -2M
EPS	AUD -0
F Score	3
FCF	AUD -1.7M
FCF EV Yield	-36.74x
FCF Per Share	AUD -0
Financing CF	2,109,717
Fiscal Year End	June
Founded	1,984
Income Tax	AUD -44
Investing CF	-4,294
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2024-05-28
Last Split Type	Reverse
Ma150	0
Ma150ch	5.26%
Ma20	0
Ma20ch	11.11%
Net CF	380,143
Next Earnings Date	2026-08-28
Open	0
Ppne	28,320
Price Date	2026-07-23
Relative Volume	0.2x
Revenue	1,727,959x
Tax By Revenue	-0x
Volume	250,000
Z Score	-107.1

ASX/BP8 (ASX/BP8)

Coverage state: Market snapshot only — no published research

Generate the first ASX/BP8 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/BP8

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/BP8 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ASX/BP8

Frequently asked questions